First In Nation: UC San Diego Health Offers Treatment For Hereditary Amyloidosis
![](./upload/news/image_1660849812_41150730.jpg)
UC San Diego Health is first in the nation to offer a new injectable medication to patients with nerve damage caused by hereditary transthyretin amyloidosis, a rare disease that can be fatal without management.